Total Payments
$16,243
2024 Payments
$1,958
Companies
58
Transactions
603
Medicare Patients
2,421
Medicare Billing
$265,323
Payment Breakdown by Category
Food & Beverage$12,247 (75.4%)
Education$2,279 (14.0%)
Travel$1,718 (10.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,247 | 588 | 75.4% |
| Education | $2,279 | 4 | 14.0% |
| Travel and Lodging | $1,718 | 11 | 10.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $5,100 | 25 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,242 | 136 | $0 (2024) |
| ABBVIE INC. | $1,686 | 86 | $0 (2024) |
| Janssen Biotech, Inc. | $1,254 | 64 | $0 (2024) |
| Davol Inc. | $836.07 | 11 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $729.74 | 53 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $535.35 | 30 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $287.92 | 16 | $0 (2017) |
| Vioptix Inc | $248.02 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $241.17 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,958 | 79 | Janssen Biotech, Inc. ($518.26) |
| 2023 | $1,615 | 79 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($364.64) |
| 2022 | $2,049 | 77 | Intuitive Surgical, Inc. ($604.76) |
| 2021 | $1,763 | 89 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($397.59) |
| 2020 | $977.18 | 57 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($354.67) |
| 2019 | $3,156 | 78 | Intuitive Surgical, Inc. ($2,098) |
| 2018 | $1,387 | 66 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($417.02) |
| 2017 | $3,339 | 78 | Intuitive Surgical, Inc. ($2,256) |
All Payment Transactions
603 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.25 | General |
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $130.72 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.86 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $244.53 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/07/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/04/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $18.96 | General |
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/10/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Immunology | ||||||
| 10/01/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.39 | General |
| Category: Immunology | ||||||
| 09/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 561 | 665 | $139,902 | $65,777 |
| 2022 | 14 | 633 | 718 | $122,747 | $53,095 |
| 2021 | 16 | 601 | 660 | $145,884 | $74,007 |
| 2020 | 14 | 626 | 728 | $149,627 | $72,444 |
Total Patients
2,421
Total Services
2,771
Medicare Billing
$265,323
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 44207 | Partial removal of large bowel and reattachment to rectum using an endoscope | Facility | 2023 | 13 | 13 | $24,791 | $17,981 | 72.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 60 | 63 | $32,823 | $12,513 | 38.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 54 | 54 | $21,168 | $9,267 | 43.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $7,049 | $4,438 | 63.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 42 | $5,586 | $3,585 | 64.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 80 | 160 | $6,935 | $3,571 | 51.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $6,664 | $2,977 | 44.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $8,875 | $2,867 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 39 | $3,866 | $2,574 | 66.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 18 | 19 | $8,759 | $2,278 | 26.0% |
| 45300 | Diagnostic exam of rectum and lower large bowel using an endoscope | Office | 2023 | 19 | 19 | $2,527 | $1,749 | 69.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $2,381 | $1,376 | 57.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 153 | 157 | $8,478 | $601.05 | 7.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 68 | 68 | $35,428 | $12,998 | 36.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 53 | 54 | $21,168 | $9,333 | 44.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $11,245 | $7,346 | 65.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 56 | $7,574 | $4,618 | 61.0% |
| 45300 | Diagnostic exam of rectum and lower large bowel using an endoscope | Office | 2022 | 45 | 46 | $6,278 | $4,042 | 64.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 20 | 20 | $7,840 | $3,472 | 44.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 89 | 156 | $6,320 | $3,321 | 52.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $8,298 | $2,353 | 28.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $4,255 | $1,485 | 34.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $1,576 | $1,042 | 66.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 15 | $1,410 | $963.48 | 68.3% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2022 | 11 | 11 | $1,320 | $841.38 | 63.7% |
About Dr. John Dvorak, MD
Dr. John Dvorak, MD is a Colon & Rectal Surgery healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902807985.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Dvorak, MD has received a total of $16,243 in payments from pharmaceutical and medical device companies, with $1,958 received in 2024. These payments were reported across 603 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($12,247).
As a Medicare-enrolled provider, Dvorak has provided services to 2,421 Medicare beneficiaries, totaling 2,771 services with total Medicare billing of $265,323. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Colon & Rectal Surgery
- Location Lexington, KY
- Active Since 08/02/2005
- Last Updated 09/24/2010
- Taxonomy Code 208C00000X
- Entity Type Individual
- NPI Number 1902807985
Products in Payments
- Da Vinci Surgical System (Device) $5,100
- XIFAXAN (Drug) $1,599
- STELARA (Biological) $860.77
- RINVOQ (Biological) $491.02
- SKYRIZI (Biological) $484.79
- TREMFYA (Drug) $466.56
- TRULANCE (Drug) $398.61
- GATTEX (Drug) $369.75
- ENTYVIO (Biological) $364.14
- HUMIRA (Biological) $294.85
- Humira (Biological) $284.57
- PHASIX (Device) $279.22
- T. Ox Tissue Oximeter (Device) $248.02
- DUPIXENT (Biological) $245.72
- REBYOTA (Biological) $219.53
- Entyvio (Biological) $208.07
- MOVIPREP (Drug) $189.82
- DIFICID (Drug) $185.52
- ZEPOSIA (Drug) $164.49
- Phasix (Device) $147.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Colon & Rectal Surgery Doctors in Lexington
Alfred Cohen
Colon & Rectal Surgery — Payments: $199,984
Colon & Rectal Surgery $199,984
Jennifer Rea, Md, MD
Colon & Rectal Surgery — Payments: $47,064
Colon & Rectal Surgery $47,064
Bruce Belin, Md, MD
Colon & Rectal Surgery — Payments: $23,534
Colon & Rectal Surgery $23,534
Mr. David Svetich, Md, MD
Colon & Rectal Surgery — Payments: $11,205
Colon & Rectal Surgery $11,205
Dr. Charles Papp, Md, MD
Colon & Rectal Surgery — Payments: $9,197
Colon & Rectal Surgery $9,197
Erin Wolf Horrell, Md, MD
Colon & Rectal Surgery — Payments: $108.85
Colon & Rectal Surgery $108.85